Taltz (ixekizumab) is an interleukin-17A antibody from Eli Lilly for plaque psoriasis, psoriatic arthritis and axial spondyloarthritis, supplied as an 80 mg autoinjector or pre-filled syringe that is stored refrigerated at 2 to 8 °C.
M Care Exports supplies Taltz (ixekizumab), the Eli Lilly IL-17A antibody, to hospital pharmacies, importers and tender desks in the GCC, Africa and the UK. If you are looking for Taltz 80 mg autoinjectors or pre-filled syringes, send the destination, the presentation and the quantity, and we quote per destination.
Ixekizumab exporter and bulk supplier from India.
"We need a partner for Taltz" is a typical dermatology or rheumatology formulary enquiry. M Care is a merchant-exporter: we quote the originator product against your specification and align the offer with your destination's registration route. Taltz is a refrigerated biological that patients may self-inject after training, so the quote turns on autoinjector or syringe, pack size, quantity, the registration route and the 2 to 8 °C lane. Other IL-17 and IL-23 options that buyers list beside it are on our secukinumab (Cosentyx) and risankizumab (Skyrizi) pages. Each has its own label, so we quote them as separate lines.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Interleukin-17A antagonist monoclonal antibody, sourced and documented for export.
Ixekizumab is marketed as Taltz by Eli Lilly and Company in the US, and by Eli Lilly and Company (Ireland) Limited as marketing authorisation holder in the EU and UK. The US label lists moderate-to-severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy, plus active psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis in adults. The EU and UK texts list moderate to severe plaque psoriasis in adults and in children from 6 years weighing at least 25 kg, psoriatic arthritis, radiographic and non-radiographic axial spondyloarthritis, and juvenile psoriatic arthritis and enthesitis-related arthritis from 6 years weighing at least 25 kg. The US label describes an 80 mg/mL autoinjector and 80 mg/mL, 40 mg/0.5 mL and 20 mg/0.25 mL pre-filled syringes. The UK SmPCs describe 80 mg in 1 mL as a pre-filled pen or pre-filled syringe, in packs of 1, 2 or 3 (not all marketed).
Active ingredient
Ixekizumab. Interleukin-17A antagonist monoclonal antibody.
Forms and strengths
80 mg/mL single-dose autoinjector (pre-filled pen); 80 mg/mL single-dose pre-filled syringe; 40 mg/0.5 mL pre-filled syringe (US label); 20 mg/0.25 mL pre-filled syringe (US label).
Indications
Ixekizumab, an IL-17A antibody for plaque psoriasis, psoriatic arthritis and axial spondyloarthritis. Sold as Taltz and supplied to GCC, African and UK buyers as a cold-chain biological.
Administration
Subcutaneous. Solution for injection in autoinjector (pen) or pre-filled syringe.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers are hospital pharmacists and dermatology or rheumatology formulary leads, MoH and hospital tender desks, and licensed importers and distributors in the GCC, Africa and the UK. Typical enquiries read "I'm looking for Taltz 80 mg autoinjectors" or "We need a partner for Taltz for a hospital tender". Each destination has its own registration route, for example the Emirates Drug Establishment (EDE) in the UAE, NAFDAC in Nigeria and the MHRA in the UK, and we confirm the route before quoting. Taltz is a chronic therapy with maintenance dosing of 80 mg every 4 weeks in the US and UK labels, so tender buyers usually ask for a quantity plan across the year, not a single shipment.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on ixekizumab.
Taltz is a cold-chain biological: store at 2 to 8 °C, do not freeze, protect from light. The UK SmPCs allow storage unrefrigerated for up to 5 days at a temperature not above 30 °C, and the US label gives patients and caregivers the same 5 days at up to 30 °C, with the product not to return to the fridge afterwards. Build the distributor lane to 2 to 8 °C and treat that allowance as a patient-side buffer, not a transport plan. The UK SmPCs give a shelf life of 2 years. In the US label the starting dose for adult plaque psoriasis, psoriatic arthritis and ankylosing spondylitis is 160 mg, given as two 80 mg injections, so pack counts matter for the first month. The US label says 20 mg and 40 mg paediatric doses prepared from the 80 mg/mL syringe should only be given by a qualified healthcare professional, and the UK text says that if the 40 mg syringe is not available, doses below 80 mg must be prepared by a healthcare professional. Tuberculosis evaluation before the first dose and a record of product name and batch number are label points your clinic will ask about.
The documentation pack a regulator actually asks for.
Taltz is an originator biological from Eli Lilly. The EMA lists Eli Lilly and Company (Ireland) Limited as the marketing authorisation holder, with authorisation issued on 25 April 2016, and the UK SmPC gives the same holder and first-authorisation date. The US label names Eli Lilly and Company, Indianapolis, as the US licence holder. The EMA medicines list shows Taltz as the only authorised ixekizumab medicine, and it is not a biosimilar; DailyMed and emc also list only Taltz, so enquiries today are for the originator. M Care documentation covers batch certificates of analysis, export documents and destination-aligned dossier support where the regulator requires it, with the cold-chain lane confirmed per shipment. M Care makes no manufacturing or quality-status claim for itself beyond merchant-exporter documentation.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside ixekizumab.
Etanercept
TNF-alpha inhibitor (biologic) · rheumatoid arthritis, psoriasis · TB screening before use
Ustekinumab
IL-12/23 antagonist · psoriasis, Crohn's disease, ulcerative colitis
Adalimumab
TNF-alpha blocker · rheumatoid arthritis, psoriasis, IBD
All allergy & immunology
The full category listing for procurement desks.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for ixekizumab.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Ixekizumab supply, the specific questions.
What decides the landed price of Taltz for an importer?
We do not publish prices. The landed cost of Taltz depends on the presentation (autoinjector or pre-filled syringe), pack size, quantity, the registration route in your destination, the 2 to 8 °C cold-chain lane and Incoterms. Refrigerated freight is a real cost line for a biological. M Care Exports quotes per destination once you send the presentation, volume and country.
What is Taltz 80 mg and how is the autoinjector supplied?
Taltz 80 mg is a single-dose solution, 80 mg in 1 mL, for subcutaneous injection. The US label lists an 80 mg/mL autoinjector in cartons of 1, 2 or 3, and an 80 mg/mL pre-filled syringe. The UK SmPCs list the pre-filled pen and the pre-filled syringe in packs of 1, 2 or 3, noting that not all pack sizes may be marketed. The US label also lists 40 mg/0.5 mL and 20 mg/0.25 mL pre-filled syringes. Tell us the presentation your destination registers and we quote that line.
What is the Taltz dosing schedule for plaque psoriasis?
For adults, the US and UK texts give 160 mg at week 0, then 80 mg at weeks 2, 4, 6, 8, 10 and 12, then 80 mg every 4 weeks. For children, dosing is by weight. Above 50 kg it is 160 mg at week 0, then 80 mg every 4 weeks. At 25 to 50 kg it is 80 mg at week 0, then 40 mg every 4 weeks. The US label adds an under-25 kg band (40 mg, then 20 mg every 4 weeks), while the UK SmPC does not recommend Taltz below 25 kg. The prescriber sets the dose.
What are the key Taltz side-effect warnings in the label?
The US and UK labels warn about infections, so tuberculosis should be evaluated before starting, and active TB is a contraindication in the UK text. Both warn of serious hypersensitivity, including anaphylaxis, and of new or worsening inflammatory bowel disease, and both advise against live vaccines. The US label also reports severe eczematous eruptions after marketing. Full adverse-reaction detail is in the current label, and clinical questions belong with the prescriber.
Which conditions is Taltz labelled for, and where is the FDA label?
The FDA label (DailyMed, Eli Lilly) lists plaque psoriasis from 6 years, active psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis in adults. The EU and UK texts add juvenile psoriatic arthritis and enthesitis-related arthritis from 6 years weighing at least 25 kg. Other uses are not labelled indications. Our source list below links the DailyMed label, the EMA page and the UK SmPCs.
Is there a generic or biosimilar of Taltz, and does it need a cold chain?
The EMA medicines list shows Taltz as the only authorised ixekizumab medicine in the EU, and we found no other ixekizumab product on DailyMed or emc, so supply today is the originator, and M Care confirms status per enquiry. Taltz needs a refrigerated lane at 2 to 8 °C, must not be frozen, and the UK SmPC gives a 2-year shelf life. The US label states the 5-day unrefrigerated allowance up to 30 °C for patients and caregivers, so we plan lanes to the fridge standard and check remaining shelf life on arrival.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-08.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.